Advertisement

How Knowledge About Drugs Is Produced in Cryptomarkets

  • Angus BancroftEmail author
Chapter
Part of the Palgrave Studies in Cybercrime and Cybersecurity book series (PSCYBER)

Abstract

This chapter develops the theme of faith being put in technology over community to consider the differences between automatic trust systems and users’ and vendors’ own judgements when it comes to drug quality. The chapter explores the different kinds of knowledge that are employed to assess and ensure drug quality. Some of this knowledge can be reflected in published market ratings but much has to be developed and shared between users. Drug quality is not a single attribute that can be measured by one metric. It is a multivariate element that changes depending on the purpose for which it is being used and the context in which it is being taken.

References

  1. Coomber, R. (1997a). Dangerous drug adulteration—An international survey of drug dealers using the internet and the World Wide Web (WWW). International Journal on Drug Policy, 8, 71–81.Google Scholar
  2. Coomber, R. (1997b). The adulteration of drugs: What dealers do to illicit drugs, and what they think is done to them. Addiction Research and Theory, 5(4), 297–306.CrossRefGoogle Scholar
  3. Decorte, T. (2001). Quality control by cocaine users: Underdeveloped harm reduction strategies. European Addiction Research, 7(4), 161–175.CrossRefGoogle Scholar
  4. DoctorX. (2019). Use and abuse of drug checking by cryptomarkets vendors. International Energy Control. Retrieved 17 April 2019, from https://energycontrol-international.org/use-and-abuse-of-drug-checking-by-cryptomarkets-vendors/.
  5. Du Toit, B. (1977). Drugs, rituals and altered states of consciousness. Rotterdam: AA Balkema.Google Scholar
  6. Grund, J. P. C. (1993). Drug use as a social ritual. Rotterdam: Instituut voor Verslavingsonderzoek, Erasmus University Rotterdam.Google Scholar
  7. Kücklich, J. (2005). Precarious playbour: Modders and the digital games industry. Fibreculture, 5(1).Google Scholar
  8. Martin, E. (2006). The pharmaceutical person. BioSocieties, 1(3), 273–287.CrossRefGoogle Scholar
  9. Parkin, S. G. (2013). Habitus and drug using environments: Health, place and lived-experience. Farnham, Surrey, England: Ashgate. https://www.dawsonera.com/abstract/9781409464938.

Copyright information

© The Author(s) 2020

Authors and Affiliations

  1. 1.School of Social and Political ScienceUniversity of EdinburghEdinburghUK

Personalised recommendations